AI-Enhanced Drug Discovery Symposium hosted at the University of Sydney. The event will bring together leading voices from research, industry, and government to explore how AI is transforming drug discovery from enabling infrastructure and omics to regulatory frameworks and commercialisation.
Symposium program highlights:
- Opening Keynotes from NSW Chief Scientist Prof. Hugh Durrant-Whyte and AIEDD CRC leadership team.
Panel discussions:
- Panel 1: Drug Discovery Challenges, Industry Trends, and Government Policy
- Panel 2: Innovation, Infrastructure, and Emerging R&D
Roundtables:
- AI Algorithms & Applications
- Next-Gen Omics & Data Access
- Building AI Infrastructure for Drug Discovery
- Networking Opportunities
We are thrilled to be representing ARGF in Panel 2: Innovation, Enabling Infrastructure, Technologies, and Emerging R&D in Drug Discovery. This session will be chaired by Professor Ben Eggleton (Pro-Vice Chancelor, Research, the University of Sydney), and will feature speakers from AWS, ThermoFisher, Propel Health AI, Quantum Australia, and others.
